Commonwealth of Pennsylvania Public School Empls Retrmt SYS Purchases 708 Shares of Doximity, Inc. (NASDAQ:DOCS)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Doximity, Inc. (NASDAQ:DOCS) by 2.6% during the 4th quarter, Holdings Channel reports. The fund owned 28,299 shares of the company’s stock after buying an additional 708 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Doximity were worth $1,511,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in DOCS. Global Retirement Partners LLC raised its position in shares of Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after purchasing an additional 440 shares during the period. UMB Bank n.a. increased its stake in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 235 shares in the last quarter. Larson Financial Group LLC raised its holdings in Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after buying an additional 250 shares during the last quarter. Morse Asset Management Inc bought a new position in shares of Doximity in the third quarter valued at $46,000. Finally, IFP Advisors Inc grew its holdings in shares of Doximity by 344.1% during the fourth quarter. IFP Advisors Inc now owns 1,328 shares of the company’s stock valued at $71,000 after buying an additional 1,029 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on DOCS shares. Leerink Partnrs upgraded shares of Doximity from a “hold” rating to a “strong-buy” rating in a report on Friday, February 7th. Stephens started coverage on Doximity in a research note on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price objective for the company. Piper Sandler raised Doximity from a “neutral” rating to an “overweight” rating and lifted their target price for the company from $31.00 to $78.00 in a research report on Friday, February 7th. Mizuho increased their price target on Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Finally, Wells Fargo & Company reaffirmed an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Doximity has a consensus rating of “Moderate Buy” and a consensus target price of $64.22.

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 37.40% of the company’s stock.

Doximity Stock Performance

Shares of DOCS opened at $66.00 on Wednesday. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The business has a 50-day moving average of $65.07 and a 200 day moving average of $54.06. The firm has a market cap of $12.32 billion, a P/E ratio of 66.00, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.